InsiderTrades

Form 4 for EW Edwards Lifesciences

Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-06 · accession 0001225208-26-000378 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-01-06 2026-01-06 EW BOBO DONALD E JR CVP, Strategy, Corp Development M - OptEx $59.26 +11.3K 43.2K +36% +$672.0K
DM 2026-01-06 2026-01-06 EW BOBO DONALD E JR CVP, Strategy, Corp Development S - Sale+OE $85.66 -11.3K 31.9K -26% -$971.4K
D 2026-01-06 2026-01-06 EW BOBO DONALD E JR CVP, Strategy, Corp Development M - OptEx $0.00 -11.3K 34.0K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-01-06 M A 11,340 $59.26 43,210.25 D — —
2 Common Common Stock 2026-01-06 S D 2,632 $84.62 40,578.25 D — — (F2) This transaction was executed in multiple trades at prices ranging from $84.39 to $85.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
3 Common Common Stock 2026-01-06 S D 8,708 $85.98 31,870.25 D — — (F3) This transaction was executed in multiple trades at prices ranging from $85.40 to $86.10. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
4 Derivative Employee Stock Option (Right to Acquire) 2026-01-06 M D 11,340 $0.00 34,020 D $59.26 · 2019-06-08 to 2026-05-07 11,340 Common Stock